DELIVERY ORDER
Active75F40126F19103
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$210.6K
obligated · signed 2 months ago
TO OBTAIN A SCIENTIFIC CONTRACT PROFESSIONAL TO SUPPORT THE DEVELOPMENT, VALIDATION AND IMPLEMENTATION OF BIOASSAYS FOR BIOSIMILARS AND COMPLEX GENERICS, WITH A FOCUS ON INSULIN BIOSIMILARS AND GLP1R AGONIST COMPLEX GENERICS, AS PART OF A BIOASSAY RE
Performance timeline
Start
Aug 31, 2026
End
Aug 30, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Aug 30, 2027
VETS SYNERGETIC GROUP LLC
Contract 75F40126F19103
UEI
CKT7ALMJZL25
Parent Company
VETS SYNERGETIC GROUP LLC
Capabilities & Certifications
Headquarters Location
Congressional District: 10
Current Obligation
$210,648
Base + Exercised Options
$210,648
Total Ceiling Value
$210,648
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES
PSC
SUPPORT- MANAGEMENT: OTHER
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Contract Vehicle
75F40124D00020
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.